Nuvalent
Price & Volume
Stats
See moreOpen | $105.79 |
Previous Close | $104.95 |
Day Range | $105.13-$108.46 |
52W Range | $70.25-$113.01 |
Market Cap | $8.2B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$6.07 |
News
See moreYahoo Finance • last month
Nuvalent to Present Pivotal Data from ALKOVE-1 Trial of Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC at the 2026 American Society of Clinical Oncology Annual Meeting
Yahoo Finance • 2 months ago
Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC
Yahoo Finance • 2 months ago
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?
Yahoo Finance • 3 months ago
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision
About
CEO | Dr. James R. Porter Ph.D. |
CFO | Ms. Alexandra Balcom CPA, M.B.A. |
Address | One Broadway, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 234 |